首页 | 本学科首页   官方微博 | 高级检索  
     


Hypoxia-induced iNOS expression in microglia is regulated by the PI3-kinase/Akt/mTOR signaling pathway and activation of hypoxia inducible factor-1alpha
Authors:Lu Dah-Yuu  Liou Houng-Chi  Tang Chih-Hsin  Fu Wen-Mei
Affiliation:Pharmacological Institute, College of Medicine, National Taiwan University, Taipei, Taiwan.
Abstract:Exposure to hypoxia induced microglia activation and animal studies have shown that neuronal cell death is correlated with microglial activation following cerebral ischemia. Thus, it is likely that toxic inflammatory mediators produced by activated microglia under hypoxic conditions may exacerbate neuronal injury following cerebral ischemia. The hypoxia-inducible factor-1 (HIF-1) is primarily involved in the sensing and adapting of cells to changes in the O(2) level, which is regulated by many physiological functions. However, the role of HIF-1 in microglia activation under hypoxia has not yet been defined. In the current work, we investigate the signaling pathways of HIF-1alpha involved in the regulation of hypoxia-induced overexpression of inducible NO synthase (iNOS) in microglia. Exposure of primary rat microglial cultures as well as established microglial cell line BV-2 to hypoxia induced the expression of iNOS, indicating that hypoxia could lead to the inflammatory activation of microglia. iNOS induction was accompanied with NO production. Moreover, the molecular analysis of these events indicated that iNOS expression was regulated by the phosphatidylinositol 3-kinase (PI3-kinase)/AKT/ mammalian target of rapamycin (mTOR) signaling pathway and activation of hypoxia inducible factor-1alpha (HIF-1alpha). Thus, during cerebral ischemia, hypoxia may not only directly damage neurons, but also promote neuronal injury indirectly via microglia activation. In this study, we demonstrated that hypoxia induced iNOS expression by regulation of HIF-1alpha in microglia.
Keywords:CNS, central nervous system   HIF-1α, hypoxia inducible factor-1alpha   IL-1, interleukin-1   iNOS, inducible nitric oxide synthase   LY294002, 2-(4-morpholinyl)-8-henyl-1(4H)-benzopyran-4-one   mTOR, mammalian target of rapamycin   NO, nitric oxide   PD980509, 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one   PI3-kinase, phosphatidylinositol 3-kinase   ROS, reactive oxygen species   SB203580, 4-(4-fluorophenyl)-2-(4-methylsulfinylphenyl)-5-(4-pyridyl)-1H-imidazole   TNF-α, tumor necrosis factor-alpha
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号